Michael Osterholm

Michael Osterholm, the Director of the Center for Infectious Disease Research and Policy, shares insights on the alarming decision to halt federal research into mRNA vaccines. The discussion reveals potential public health crises linked to misinformation and vaccine preparedness. Amid political turmoil, Trump’s chaotic maneuvers are examined, including the fallout from his grand jury investigations and MAGA's redistricting efforts. The dialogue provides a sobering look at the need for political engagement and accountability as the next elections approach.

Prof. Michael Osterholm discusses bird flu in US dairy cows, its potential to spread to humans, and the risks of consumption. Insights on virus evolution, cross-species transmission, outbreak detection challenges, and precautions for the public. Emphasis on pandemic preparedness and surveillance in farm animals.

Michael Osterholm, Director of CIDRAP and author of The Big One, shares insights on recent cuts to mRNA vaccine funding and their implications for public health. He emphasizes the critical role of mRNA technology beyond COVID-19, discusses the troubling impact of misinformation on vaccine perceptions, and highlights the need for scientific integrity in vaccination efforts. Osterholm also initiates the Vaccine Integrity Project to enhance public understanding of vaccine efficacy, analyzing extensive research data to combat skepticism.

Michael Osterholm, a renowned epidemiologist and director at the University of Minnesota's Center for Infectious Disease Research and Policy, joins Melvin Sanicas to tackle pressing public health issues. They dive into why flu vaccines require annual updates due to the virus's rapid mutations. The conversation highlights the dangers of misinformation about vaccines and emphasizes the crucial role of accurate data and communication in rebuilding public trust. Listeners discover the importance of community preparedness against future pandemics.

Join infectious disease expert Michael Osterholm and vaccine researcher Ted Ross as they delve into the NIH's ambitious plan for a universal vaccine. They discuss the potential of a single shot for flu and COVID-19 that could last for years. The conversation covers the challenges of vaccine development, addressing public hesitancy, and the innovative COBRA program that uses AI in vaccine design. With clinical trials on the horizon, they explore the complexities of ensuring trust and efficacy in public health strategies.